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OpennessObjective. To test whether personality traits moderate type 2 diabetes (T2D) genetic risk.Methods. Using a large
community-dwelling sample (n=837,Mage= 69.59± 0.85 years, 49%males) we ﬁtted a series of linear regres-
sion models predicting glycated haemoglobin (HbA1c) from T2D polygenic risk— aggregation of small individual
effects of a large number of single nucleotide polymorphisms (SNPs) — and ﬁve personality traits. We tested the
main effects of personality traits and their interactions with T2D polygenic risk score, controlling for age and sex.
The models in the ﬁnal set were adjusted for cognitive ability, highest educational qualiﬁcation, and occupational
class. Results. Lower levels of openness were associated with heightened levels of HbA1c (β=−0.014, p= .032).
There was a signiﬁcant interaction between T2D polygenic risk score and agreeableness: lower agreeableness was
related to a stronger association between T2D polygenic risk and HbA1c (β=−0.08, p= .021). In the model ad-
justed for cognitive ability, the main effect of openness was not signiﬁcant (β=−0.08, p= .057). The interaction
between agreeableness and T2D polygenic riskwas still present after controlling for cognitive ability and socioeco-
nomic status indicators, and the interaction between conscientiousness and polygenic risk score was also signiﬁ-
cant: lower conscientiousness was associated with a stronger association between T2D polygenic risk and
HbA1c levels (β= 0.09, p= .04). Conclusions. Personality may be associated with markers of diabetes, and may
moderate the expression of its genetic risk.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Introduction
Diabetes mellitus is one of the biggest contemporary disease
burdens [1]. It is a major risk factor for health complications, including
heart disease and stroke, blindness, kidney and nervous system disease,
limb amputations, and increased risk of death [2]. In 2011 there were
366 million people with diabetes worldwide, approximately 90%
of whom had type 2 diabetes and this number is expected to rise to
552 million by 2030 [3,4]. Given the personal and social costsDisconnectedMind project. The
Centre for Cognitive Ageing and
Health and Wellbeing Initiative
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e.mottus@ed.ac.uk (R.Mõttus),
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y).
. This is an open access article underassociated with diabetes, it is imperative to ﬁnd ways to identify at-
risk individuals early, and to engage them in prevention strategies [4,5].
Behavioural factors such as unhealthy diet and physical inactivity,
as well as obesity, older age, insulin resistance, and the metabolic syn-
drome are all commonly recognized risk factors for type 2 diabetes
[6]. In addition to these, genetic risk also contributes to type 2 diabetes
development [7]. About 10% of the genetic risk is explained by known
common genetic variants [8] with the remainder being attributable
to small individual effects of a large number of single nucleotide
polymorphisms (SNPs) [9]. These small effects may not be individ-
ually detectable by current GWAS studies [9], but they may be
aggregated across thousands of SNPs to quantify diabetes genetic
risk [10–12]. The manifestation of the genetic risk may be moderat-
ed by non-genetic factors. For example, there is evidence that
dietary habits may interact with the genetic factors predisposing
to type 2 diabetes [13–16]. Psychological factors, including those
related to the aforementioned dietary habits and depression,
could moderate the expression of diabetes among those who are
at high genetic risk.
Mõttus et al. recently found that childhood cognitive ability
moderates the relationship between polygenic risk for type 2the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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genetic risk with lower cognitive ability at age 11 years were more
likely to have heightened HbA1c levels at age 70 than participants
with higher childhood cognitive ability [17]. This behavioural trait
by genetic risk interaction offers an insight into potential mecha-
nisms by which psychological characteristics may inﬂuence health
outcomes.
Besides cognitive abilities, other stable behavioural characteris-
tics such as personality traits described by the Five Factor Model
[18,19] have been associated with diabetes in both cross-sectional
[20,21] and longitudinal [22] studies. More speciﬁcally, in one
cross-sectional study, participants with diabetes had lower con-
scientiousness, agreeableness and openness [20]. In another study,
participants with diabetes had higher levels of neuroticism [21].
However, in a longitudinal study, higher levels of neuroticism were
associated with lower risk of developing type 2 diabetes [22]. In a
pooled analysis of ﬁve cohorts, lower conscientiousness was related
to higher diabetes incidence and mortality [23]. Furthermore, per-
sonality has been shown to inﬂuence a wide range of behavioural
and physiological diabetes risk factors. For example, higher neuro-
ticism and lower openness are related to obesity, high triglycerides,
hypertension, and elevated blood glucose, all of which are com-
ponents of the metabolic syndrome [24,25]. Along with higher
neuroticism and lower openness, higher levels of extraversion have
been related to aspects of diabetes-prone lifestyle such as unhealthy
dietary habits and low levels of physical activity [26,27]. In addition,
lower agreeableness has been associated with higher alcohol in-
take [28]. It is, then, possible that personality trait may inﬂuence
diabetes by moderating its genetic risk in a way similar to cognitive
abilities as shown by Mõttus et al. [17].
Speciﬁcally, we hypothesized that personality traits moderate
whether genetically at-risk individuals have higher levels of glycated
haemoglobin, a diagnostic tool for diabetes mellitus. This hypothe-
sis is based on the direct and indirect — i.e., via other risk factors,
associations between personality traits with diabetes, as well as
on the recent study [17] showing that higher cognitive ability is
protective among participants who are at high genetic risk for
diabetes.Method
Sample
Participants were community-dwelling members of the Lothian
Birth Cohort 1936 (LBC1936)— a follow-up study of the ScottishMental
Survey 1947 (SMS1947). On June 4, 1947, nearly all children born in
1936 and attending school in Scotland (n = 70,805; 35,809 boys)
sat the Moray House test of intelligence. Between the years 2004
and 2007, participants from Edinburgh and the Lothians region
were identiﬁed through the Community Health Index and media
advertisements. Of 3810 identiﬁed participants, 3686 were identi-
ﬁed to take part in the follow-up study. In total, 2318 responses
were received, of which 1226 met the eligibility criteria to take
part in the study. The ﬁnal number of tested LBC1936 participants
was 1091 [29]. Participants who dropped out of the study during
the follow-up time were, on average, of lower intelligence and
poorer health status than those assessed in the follow-up, but
these difference were relatively small [29]. Full details on the
recruitment and testing procedures are provided elsewhere [30].
Of the initial 1091 LBC1936 members, complete data on age, sex,
personality traits, HbA1c, and genetic risk were available for 837
participants (Mage = 69.59 ± 0.85 years, 48.7% males). All partici-
pants provided written informed consent. Ethical approval was
obtained from the Ethics the Multi-Centre Research Ethics Committee
for Scotland.Measures
Personality
Personality was assessed using the 60-item NEO Five-Factor In-
ventory (NEO-FFI), a valid and reliable instrument designed to assess
the ﬁve personality domains — neuroticism, extraversion, openness,
agreeableness, and conscientiousness — of the Five Factor Model
[31]. Approximately 50% of the variance in personality traits can be
accounted for by genetic inﬂuences [32].
Glycated haemoglobin
Glycated haemoglobin (HbA1c) is typically used as an indicator of
long-term blood glucose levels [33] and as a diagnostic criterion for
diabetes mellitus [34]. About 75% of the variation in the levels of
Hba1c is due to genetic inﬂuences [35]. The HbA1c levels were analysed
from blood taken during participants' visit to the clinic, and were treat-
ed as a continuous variable.
T2D polygenic risk
All participants underwent genome-wide genotyping, conducted by
the Genetics Core Laboratory at the Wellcome Trust Clinical Research
Facility, Western General Hospital, Edinburgh, UK, using the Illumina
Human 610-Quadv1 Chip (Illumina Inc., San Diego, CA, USA). The qual-
ity control procedures included checks for gender discrepancies, indi-
vidual relatedness and non-Caucasian descent, and are fully described
elsewhere [36].
The polygenic risk score for type 2 diabetes was calculated for
each member of the LBC1936 following a previously published meta-
analysis on the association between type 2 diabetes and approximately
121,000 SNPs. The meta-analysis comprised 34,840 participants with
type 2 diabetes diagnosis and 114,981 healthy controls [8]. The ge-
netic risk score was estimated by inclusion of all available SNPs
(n = 120,991) based on a meta-analysed by Morris et al. [17]. The
meta-analytic effect size of each of the SNPs was transformed into a
Z-score and multiplied by the number of copies (0/1/2) of the effect
allele carried by the individual. These individual risks across all SNPs
were summed to form participants' type 2 diabetes all-inclusive poly-
genic risk score. The calculations were done using PLINK software
[37]. A more detailed description of the scoring procedure is provided
elsewhere [38].
Covariates
Age and sex
Sex was coded as 0 for females and 1 for males. Age was treated as a
continuous variable.
Cognitive ability
Cognitive ability at age 70 was assessed using the Moray House Test
no. 12. The test consisted of a variety of items designed to assess reason-
ing ability, e.g., word classiﬁcation, analogies, reasoning, and spatial
items [30]. Cognitive ability was treated as a continuous variable.
SES indicators
Highest educational qualiﬁcation was classiﬁed into ﬁve categories
ranging from ‘no qualiﬁcation’ to ‘university degree’. Occupational
class was assessed on a ﬁve-point scale ranging from ‘manual labour’
to ‘professional’ [39]. Women who reported lower occupational class
than their spouse were classiﬁed according to their spouses. Both the
highest educational qualiﬁcation and occupational class were treated
as continuous variables.
Analyses
We ﬁt a series of linear regressionmodels predicting HbA1c from its
polygenic risk score and ﬁve personality traits. Models 1–5 tested the
305I. Čukić et al. / Journal of Psychosomatic Research 79 (2015) 303–308main effects of each of the ﬁve personality domains, and their interac-
tions with polygenic risk. Model 6 tested the main effects of all ﬁve
personality traits taken together and their interactions with polygenic
risk. Finally, we ran the same set of models, but controlling for the
effects of cognitive ability and socioeconomic status. All models were
ﬁtted using R 3.1.3 [40].
Results
Ninety-one (10.9%) participants showed HbA1c levels higher than
the diagnostic cut-off value (6.5 mmol/L) that would lead to a diabetes
diagnosis [41]. Polygenic risk score is known to predict the HbA1c
measure in the LBC36 sample [17] and did so in our study (β= 0.15,
p b .001). Participants with higher levels of HbA1c had higher neuro-
ticism, were less open to experience and had lower agreeableness
than those with lover levels (Table 1). The differences between partici-
pants with normal and heightened levels of HbA1c were signiﬁcant for
openness (p= .020) and agreeableness (p= .004), but not for neuro-
ticism (p = .21). The full list of group comparisons is presented in
Table 1.
Of personality traits, openness to experience and agreeableness
were negatively correlated with HbA1c (r = −0.07, p = 0.028, and
r=−0.08, p= 0.013, respectively). The only personality trait related
to T2D polygenic risk was agreeableness (r =−0.08, p = 0.021). The
matrix of correlation between all variables in the study is presented in
Table S1.
First, we testedwhether personality traitsmoderated the expression
of genetic risk for type 2 diabetes. Models 1–5 (Table 2) included the
main effect of one personality trait at a time, and its interaction with
polygenic risk, whilst controlling for the effects of age and sex. Lower
levels of openness were related to heightened HbA1c (β = −0.07,
p = .036), but the interaction between openness and polygenic risk
was not signiﬁcant. Furthermore, in the model including personality
trait agreeableness, lower agreeableness was related to heightened
levels of HbA1c (β = −0.07, p = .033), and the interaction be-
tween agreeableness and T2D polygenic risk was also signiﬁcant
(β= −0.07, p = .033) — the nature of the interaction is considered
below. The ﬁnal model (Table 2) included the effects of all ﬁve person-
ality traits: neuroticism, openness, agreeableness, extraversion and
conscientiousness. In this model, both the main effects of personality
traits, and the interactions between personality traits and T2Dpolygenic
risk were comparable to those in models 1–5. The main effect of open-
ness to experience was related to HbA1c — higher openness was asso-
ciated with lower HbA1c levels (β = −0.07, p = .040), and theTable 1
Descriptive statistics of the sample by HbA1c levels.
Total
Low
M (SD) M (SD)
HbA1c 5.92 (0.74) 5.73 (0.34)
Neuroticism 17.09 (7.71) 16.97 (7.69)
Extraversion 26.98 (5.90) 26.96 (5.88)
Openness 26.04 (5.79) 26.20 (5.77)
Agreeableness 33.42 (5.33) 33.60 (5.31)
Conscientiousness 34.71 (5.99) 34.78 (5.96)
Age 69.58 (0.85) 69.57 (0.86)
Cognitive Ability 101.35 (13.76) 101.87 (13.21)
Education 1.72 (1.29) 1.77 (1.30)
Occupation 2.37 (0.91) 2.34 (0.90)
n (%)
Gender
Male 358 (48.0)
Female 388 (52.0)
Note. Low HbA1c b 6.5 mmol/L, n= 746; High HbA1c ≥ 6.5 mmol/L, n= 91; Total n= 837. Edinteraction between openness and polygenic risk was not signiﬁcant.
The main effect of agreeableness was no longer signiﬁcant
(β = −0.05, p = .20), although similar in magnitude to the one in
Model 4. However, the interaction between agreeableness and T2D
polygenic risk was still signiﬁcant (β= −0.08, p = .021). No other
main effects of personality traits or interaction terms with T2D poly-
genic risk were signiﬁcant in this model (Table 2).
The next set of models were the same as Models 1–6, but adjusted
for the effects of cognitive ability at age 70, highest educational attain-
ment, and occupational class, in addition to age and sex (Table 3). In
the model that included the effects of one personality trait at a time,
adjusting for these covariates attenuated the effects of openness. This
time, neither the main effect of openness (β= −0.04, p = .27), nor
the interaction between openness and T2D was signiﬁcant. This was
not speciﬁc to the inclusion of cognitive ability or socioeconomic status
indicators — including just one of the confounders at a time produced
the same effect. However, both the main effect of agreeableness
(β = −0.07, p = .028) and its interaction with T2D polygenic risk
(β = −0.05, p = .010) were still signiﬁcant after adjusting for the
effects of IQ, educational attainment and occupational class. In the
model that included all ﬁve personality traits along with the covariates
(Model 6a), the main effect of agreeableness was not signiﬁcant
(β=−0.06, p = .091). However, the interaction between agreeable-
ness and polygenic risk was still signiﬁcant (β = −0.07, p = .036).
Finally, the interaction between conscientiousness and diabetes poly-
genic risk was signiﬁcant in the model including all traits and all covar-
iates (β= 0.09, p= .015).
To clarify the observed interactions between T2D polygenic risk and
personality traits agreeableness and conscientiousness, we performed a
median split of participants on the two personality traits and predicted
HbA1c from T2D polygenic risk separately in the lower and higher
agreeableness groups. The differential predictions are presented
in Figs. 1 and 2, respectively and suggest that the polygenic risk for dia-
betes was more strongly associated with HbA1c levels among part-
icipants with lower levels of agreeableness, and lower levels of
conscientiousness.
We ran an additional set of models to address whether the associa-
tions between personality traits and T2D polygenic risk were mediated
by depression. Controlling for depression did not affect the interaction
between conscientiousness and type 2 diabetes polygenic risk
(β= 0.09, p = .017). However, the interaction between agreeable-
ness and T2D polygenic risk dropped below the signiﬁcance thresh-
old (β = −0.06, p = .051). The set of models controlling for
depression is presented in full in Table S2 of SupplementaryMaterial.HbA1c levels Comparisons
High Low vs. high
M (SD) t p
7.54 (1.04) −34.54 b .001
18.05 (7.88) −2.77 .20
27.13 (6.16) −0.26 .80
24.67 (5.82) 2.39 .017
31.89 (5.23) 2.90 .004
34.12 (6.23) 0.99 .32
69.72 (0.79) −1.65 .10
97.01 (17.17) 3.16 .002
1.32 (1.14) 3.15 .002
2.56 (0.93) 3.15 .036
n (%) X2 p
1.30 .25
50 (54.9)
41 (45.01)
ucation = highest educational attainment. Occupation = occupational class.
Table 2
Standardized betas (standard errors) in the models predicting HbA1c levels using type 2 diabetes (T2D) polygenic risk and personality traits.
Model 1 Model 2 Model 3 Model 4 Model 5 Model 6
β (SE) p β (SE) p β (SE) p β (SE) p β (SE) p β (SE) p
Intercept −6.87 (2.65) .009 −6.93 (2.65) .009 −7.03 (2.62) .007 −6.64 (2.61) .011 −6.81 (2.67) .011 −6.34 (2.69) .019
Age 0.00 (0.00) .009 0.00 (0.00) .010 0.00 (0.00) .008 0.00 (0.00) .012 0.00 (0.00) .011 0.00 (0.00) .020
Male vs. female 0.03 (0.07) .69 0.04 (0.06) .59 0.05 (0.06) .48 0.07 (0.07) .32 0.04 (0.06) .50 0.07 (0.07) .33
T2D polygenic risk 0.15 (0.03) b .001 0.14 (0.03) b .001 0.14 (0.03) b .001 0.12 (0.32) b .001 0.15 (0.03) b .001 0.12 (0.03) b .001
Neuroticism 0.04 (0.03) .21 0.01 (0.04) .89
N × T2D polygenic risk 0.05 (0.03) .11 0.05 (0.04) .20
Extraversion −0.03 (0.03) .36 0.01 (0.04) .76
E × T2D polygenic risk −0.01 (0.81) .81 0.01 (0.04) .80
Openness −0.07 (0.03) .036 −0.07 (0.03) .04
O × T2D polygenic risk 0.02 (0.03) .41 0.05 (0.03) .12
Agreeableness −0.07 (0.03) .033 −0.05 (0.04) .20
A × T2D polygenic risk −0.07 (0.03) .033 −0.08 (0.03) .021
Conscientiousness −0.05 (0.03) .12 −0.04 (0.04) .30
C × T2D polygenic risk 0.01 (0.03) .77 0.06 (0.04) .12
Note. n= 837; N = neuroticism, E = extraversion, O = openness, A = agreeableness, C = conscientiousness.
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The current ﬁndings suggest that lower levels of openness are asso-
ciated with higher levels of HbA1c. However, this association did not
remain after controlling for cognitive ability, although the effect size
remained similar in magnitude. Furthermore, the genetic risk for diabe-
tes wasmore strongly associated with HbA1c levels among participants
who were lower in agreeableness and lower in conscientiousness,
though the latter was true only in models that adjusted for cognitive
ability, SES indicators, and included all ﬁve personality traits.
Our ﬁnding that lower openness was related to higher levels of
HbA1c is consistent with a cross-sectional study [20]. However, the
link between openness and HbA1c was explained by the association
between openness and cognitive ability, which was both previously
reported [42] and found in the current study (r= .26). Cognitive ability
has been associated with diabetes onset [17,43], and moderates the
expression of its T2D genetic risk [17].
We also found that lower agreeableness enhanced the expression of
the genetic risk for diabetes. One possible confounding mechanism is
through links of personality with socioeconomic status [44]. Lower
agreeableness is associated with lower levels of education, an indicator
of socioeconomic status [45], which is in turn associated with poorer
health in general [46], and type 2 diabetes prevalence in particular
[47]. Including indicators of socioeconomic status, namely educational
attainment and occupational status, attenuated the strength of theTable 3
Standardized betas (standard errors) in themodels predicting HbA1c levels using type 2 diabete
occupational class.
Model 1 Model 2 Model
β (SE) p β (SE) p β (SE)
Intercept −5.96 (2.62) .023 −5.86 (2.62) .025 −6.21 (2.60)
Age 0.00 (0.00) .019 0.00 (0.00) .020 0.00 (0.00)
Male vs. female 0.02 (0.07) .80 0.01 (0.06) .82 0.02 (0.06)
T2D polygenic risk 0.14 (0.03) b .001 0.13 (0.03) b .001 0.13 (0.03)
Cognitive ability −0.08 (0.03) .034 −0.09 (0.04) .016 −0.07 (0.04)
Highest qualiﬁcation −0.08 (0.04) .010 −0.08 (0.03) .008 −0.08 (0.03)
Occupational class −0.04 (0.04) .37 −0.04 (0.03) .39 −0.05 (0.04)
Neuroticism 0.02 (0.03) .64
N × T2D polygenic risk 0.03 (0.03) .36
Extraversion −0.04 (0.03) .19
E × T2D polygenic risk 0.01 (0.03) .79
Openness −0.04 (0.03)
O × T2D polygenic risk .03 (0.03)
Agreeableness
A × T2D polygenic risk
Conscientiousness
C × T2D polygenic risk
Note. n= 812; T2D= type 2 diabetes, N = neuroticism, E = extraversion, O = openness, A =interaction between agreeableness and T2D polygenic risk, but this
attenuation was very small in size (β = −0.08 in the unadjusted
model compared to β=−0.07 in the adjusted model). On the other
hand, lower agreeablenessmay lead to higher expression of T2D genetic
risk via its associationswith health harming behaviours [44] and overall
unhealthy lifestyle factors [28,48]. Another mechanism may be that
lower agreeableness is linked with lower trust in healthcare system
and poor patient–doctor communication, whichmay lower the chances
of diabetes symptom detection or impair their effective management
[44].
The ﬁnding that the interaction between polygenic risk and consci-
entiousness was signiﬁcant in the fully adjusted model suggests that
variance unique to conscientiousness is associated with lower expres-
sion of the genetic risk for diabetes. This is in linewith a previous report
that found lower levels of conscientiousness in people with diabetes
than in those without the disease [20]. Furthermore, conscientiousness
is consistently associated with beneﬁcial health outcomes, including
longer life span [49]. This is not surprising, as conscientiousness is linked
to health promoting behaviours, such as healthier diet and exercise [50]
and better adherence to medical treatment [44].
The present study had some limitations. First, we were not able to
distinguish between type 1 and type 2 diabetes. Given that genetic
risk for type 2 diabetes is likely different from that of type 1 diabetes
[51–54] and that the two forms of the disease have different me-
chanisms of action [55], the role of personality traits as potentials (T2D) polygenic risk and personality traits controlling for cognitive ability, education and
3 Model 4 Model 5 Model 6
p β (SE) p β (SE) p β (SE) p
.017 −5.49 (2.59) .034 −5.64 (2.64) .033 −5.56 (2.65) .036
.013 0.00 (0.00) .027 0.00 (0.00) .026 0.00 (0.00) .030
.75 0.05 (0.07) .48 0.02 (0.06) .76 0.07 (0.07) .35
b .001 0.13 (0.03) b .001 0.014 (0.03) b .001 0.11 (0.03) b .001
.064 −0.06 (0.04) .11 −0.09 (0.04) .017 −0.08 (0.04) .057
.013 −0.09 (0.03) .005 −0.09 (0.03) .007 −0.08 (0.03) .009
.21 −0.04 (0.04) .31 −0.04 (0.03) .35 −0.04 (0.04) .057
−0.03 (0.04) .43
0.04 (0.04) .31
−0.03 (0.04) .50
0.01 (0.03) .71
.27 −0.03 (0.04) .35
.36 0.05 (0.03) .10
−0.07 (0.03) .028 −0.06 (0.04) .091
−0.05 (0.03) .010 −0.07 (0.03) .036
−0.05 (0.03) .15 −0.03 (0.04) .34
0.04 (0.03) .16 0.09 (0.04) .015
agreeableness, C = conscientiousness.
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Fig. 1. Association between HbA1c levels and genetic risk for type 2 diabetes in high
and low agreeableness groups. Note. Shaded lines represent 95% conﬁdence intervals.
Correlations between diabetes polygenic risk and HbA1c in low and high agreeableness
groups: r(322) = .17, p= .002 and r(331) = .13, p= .02, respectively.
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pants reported taking insulin. Removing these participants from the
analyses did not alter present results. Second, our sample was relatively
small for a genetically informative design. Thus, the results should be
replicated using a larger genetically informative sample. Finally, in the
present study we focused on the ﬁve personality traits as described by
the FFM. It is possible that other operationalisations of the variance in
human personality, like PEN [56], TCI [57], and MPQ [58] models,
could yield interesting ﬁndings. However, the FFM is commonly utilised
in the study of personality and health outcomes in general [44], and in
the studies relating personality and diabetes mellitus in particular
[20–23]. To better understand the observed relationships between
personality traits and diabetes, future studies should investigatewheth-
er the associations are driven by lower level,more speciﬁc descriptors of
personality, such as personality facets [59].
In conclusion, we found evidence that suggests that personality
traits may moderate the effects of common genetic variants predis-
posing to diabetes. Potential mechanisms of these associations are−0.5
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Fig. 2. Association between HbA1c levels and genetic risk for type 2 diabetes in high and
low conscientiousness groups. Note. Shaded lines represent 95% conﬁdence intervals.
Correlations between diabetes polygenic risk andHbA1c in low andhigh conscientiousness
groups: r(382) = .17, p= .001 and r(271) = .10, p= .09, respectively.lifestyle factors such as dietary habits and exercise, and general levels
of health concerns.
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